home / stock / huma / huma message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: HUMA 26% v3,4M c4.40 f103M H4.53 ML3.2 | znewcar1 | investorshangout | 08/12/2022 2:04:10 AM |
Piper Sandler price target, $17 | Glider549 | investorshub | 09/16/2021 1:44:20 PM |
YEP! $$$ | Glider549 | investorshub | 09/09/2021 9:59:56 PM |
Anyone else here in $HUMA? | nsomniyak | investorshub | 09/05/2021 3:54:42 AM |
News, Short Squeeze, Breakout and More Instantly...
DURHAM, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, announced the addition of pharmaceutical industry veteran Dr. John P. Bamforth and di...
Pluristyx, a leading provider of tools, technologies, and services for the development of cellular therapies, is pleased to announce a license agreement with Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercia...
2024-07-01 10:28:20 ET Humacyte Inc (NASDAQ: HUMA) opened close to 25% up on Monday after the Food & Drug Administration granted its ATEV a special advanced-therapy designation. Shares of the biotech firm are still down some 30% versus their year-to-date high. Why does it ma...